DK0453337T3 - Use of hexetidine or derivatives or salts thereof for the preparation of a pharmaceutical composition for ophthalmic use - Google Patents

Use of hexetidine or derivatives or salts thereof for the preparation of a pharmaceutical composition for ophthalmic use

Info

Publication number
DK0453337T3
DK0453337T3 DK91400743.0T DK91400743T DK0453337T3 DK 0453337 T3 DK0453337 T3 DK 0453337T3 DK 91400743 T DK91400743 T DK 91400743T DK 0453337 T3 DK0453337 T3 DK 0453337T3
Authority
DK
Denmark
Prior art keywords
hexetidine
salts
preparation
pharmaceutical composition
ophthalmic
Prior art date
Application number
DK91400743.0T
Other languages
Danish (da)
Inventor
Andre Salkin
Original Assignee
Andre Salkin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andre Salkin filed Critical Andre Salkin
Application granted granted Critical
Publication of DK0453337T3 publication Critical patent/DK0453337T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

The invention relates to the use of hexetidine or its non-toxic derivatives or salts, with the use envisaged for the preparation of a pharmaceutical composition having ophthalmic antiseptic activity, making possible, in particular, the therapeutic treatment of connective tissues in the absence or presence of ophthalmic prostheses, and in particular contact lenses. Application: ophthalmology.
DK91400743.0T 1990-04-18 1991-03-20 Use of hexetidine or derivatives or salts thereof for the preparation of a pharmaceutical composition for ophthalmic use DK0453337T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR909004945A FR2661091B1 (en) 1990-04-18 1990-04-18 USE OF HEXETIDINE OR ITS DERIVATIVES OR SALTS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR OPHTHALMOLOGICAL USE.

Publications (1)

Publication Number Publication Date
DK0453337T3 true DK0453337T3 (en) 1998-05-18

Family

ID=9395848

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91400743.0T DK0453337T3 (en) 1990-04-18 1991-03-20 Use of hexetidine or derivatives or salts thereof for the preparation of a pharmaceutical composition for ophthalmic use

Country Status (12)

Country Link
EP (1) EP0453337B1 (en)
JP (1) JPH04234818A (en)
AT (1) ATE158719T1 (en)
AU (1) AU643772B2 (en)
BR (1) BR9101544A (en)
CA (1) CA2039566A1 (en)
DE (1) DE69127767T2 (en)
DK (1) DK0453337T3 (en)
ES (1) ES2109937T3 (en)
FR (1) FR2661091B1 (en)
HU (1) HUT57985A (en)
MC (1) MC2217A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0512104A1 (en) * 1990-11-26 1992-11-11 Warner-Lambert Company Stabilized hexahydro-5-pyrimidinamine compounds in aqueous solution and methods for preparing same
DE10147186A1 (en) * 2001-09-25 2003-04-24 Beiersdorf Ag Synergistic antimicrobial composition, useful e.g. as cosmetic preservative and for treating skin disorders, comprises polyhexamethylene biguanide and distearyldimethylammonium chloride
US9737609B2 (en) * 2014-08-20 2017-08-22 Professional Compounding Centers Of America (Pcca) Natural suspending agent including a synergistic blend of xanthan gum and konjac powder for oral pharmaceutical suspensions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE540230A (en) * 1954-08-02
FR2552305B1 (en) * 1983-09-22 1985-12-20 Salkin Andre HIGH BACTERICIDAL COMPOSITION CONTAINING BIGUANIDE AND PYRIMIDINE
EP0215136B1 (en) * 1985-09-02 1988-06-22 Artesan Pharma Gesellschaft mit beschränkter Haftung Hexetidin-containing therapeutically active agent, method for its preparation and its use as a vaginal disinfectant
US4666517A (en) * 1986-06-04 1987-05-19 Colgate-Palmolive Co. Antiplaque oral composition

Also Published As

Publication number Publication date
DE69127767T2 (en) 1998-04-30
ATE158719T1 (en) 1997-10-15
AU7513291A (en) 1991-10-24
EP0453337A3 (en) 1992-11-25
FR2661091B1 (en) 1994-10-21
EP0453337B1 (en) 1997-10-01
HU911272D0 (en) 1991-10-28
ES2109937T3 (en) 1998-02-01
MC2217A1 (en) 1993-02-02
DE69127767D1 (en) 1997-11-06
FR2661091A1 (en) 1991-10-25
EP0453337A2 (en) 1991-10-23
BR9101544A (en) 1991-12-10
AU643772B2 (en) 1993-11-25
JPH04234818A (en) 1992-08-24
CA2039566A1 (en) 1991-10-19
HUT57985A (en) 1992-01-28

Similar Documents

Publication Publication Date Title
EE02971B1 (en) Use of droloxyfene or its salts in the manufacture of a medicament for the treatment of bone diseases
PT88985A (en) Process for the preparation of nasal and ophthalmic pharmaceutical compositions containing azelastine
DE122005000001I2 (en) Divalent metal salts of 2-N, N-di (carboxymethyl) amino-3-cyano-4-carboxymethyl-5-carboxy-thiophenic acid, processes for their preparation and pharmaceutical compositions containing them
BG106825A (en) Substituted oxazolidinones and their use in the field of blood coagulation
DE1300150T1 (en) Prostaglandin derivatives used to treat glaucoma or hypertension
NO307546B1 (en) A pharmaceutical composition containing optically pure R-ketorolac and its use
ATE69162T1 (en) PHARMACEUTICAL AND COSMETIC COMPOSITIONS BASED ON BENZOYL PEROXIDE AND QUATERNARY AMMONIUM SALTS.
DE69719931T2 (en) Use of acetylcysteine in the manufacture of a medicament for the treatment of chronic ulcers
DK164441C (en) USE OF A PIPERIDE INGREDIENT FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF PAIN
ATE82127T1 (en) N-ACETYLGLUCOSAMINE PREPARATIONS FOR BUCCAL APPLICATION.
IT9041503A0 (en) DEVICE FOR THE SURGICAL TREATMENT OF AMETROPIA
IT1238825B (en) DEVICE FOR SURGICAL CORRECTION OF AMETROPIA.
ATE84716T1 (en) 4-QUINOLINECARBONIC ACID DERIVATIVES USEFUL FOR THE TREATMENT OF SKIN AND MUCO-EPITHELIAL TISSUE DISEASES.
DK0594770T3 (en) Ophthalmological mixtures
DK0382381T3 (en) Treatment of leukocyte dysfunction with GM-CSF
DK0453337T3 (en) Use of hexetidine or derivatives or salts thereof for the preparation of a pharmaceutical composition for ophthalmic use
DK0410749T3 (en) Anthocyanidins for the treatment of ophthalmic diseases
ATE5256T1 (en) PHENYLPIPERAZIN DERIVATIVES OF 1,3,4OXADIAZOLYLPENOLS, THEIR PREPARATION AND THERAPEUTIC AGENTS CONTAINING THEM.
NO179472C (en) Solution comprising benzoxonium chloride for the treatment of contact lenses, and their use for preserving contact lenses and drugs for the eyes
DE69100171D1 (en) SYNERGISTIC COMBINATION FOR OPHTHALMIC USE.
KR890001555A (en) Uric acid excretion composition
RU93015155A (en) MEDICINE FOR THE TREATMENT OF DYSTROPHIC DISEASES AND INJURIES OF THE EYE TISSUES
ATE78160T1 (en) USE OF ''NAFTIDROFURYL'' TO TREAT NEUROPATHIES.
PT97878A (en) Process for the preparation of a pharmaceutical composition for ophthalmic use containing hexetidine or derivatives or salts thereof
ATE128866T1 (en) USE OF NAPROXEN AS A MYDRIATIC.